Mikko Sayre1,2, Gwen T Lapham3, Amy K Lee3, Malia Oliver3, Jennifer F Bobb3, Ryan M Caldeiro3, Katharine A Bradley3. 1. Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA. mns2144@cumc.columbia.edu. 2. Columbia-Bassett Program at Columbia University College of Physicians and Surgeons, Cooperstown, NY, USA. mns2144@cumc.columbia.edu. 3. Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Abstract
BACKGROUND: Most patients with substance use disorders (SUDs) never receive treatment and SUDs are under-recognized in primary care (PC) where patients can be treated or linked to treatment. Asking PC patients to directly report SUD symptoms on questionnaires might help identify SUDs but to our knowledge, this approach is previously untested. OBJECTIVE: To describe the prevalence and severity of DSM-5 SUD symptoms reported by PC patients as part of routine care. DESIGN: Cross-sectional study using secondary data. PARTICIPANTS: A total of 241,265 adult patients who visited one of 25 PC sites in an integrated health system in Washington state and had alcohol, cannabis, or other drug use screening documented in their EHRs (March 2015-July 2018) were included in main analyses if they had a positive screen for high-risk substance use defined as AUDIT-C score 7-12 points, or report of past-year daily cannabis use or any other drug use. MAIN MEASURES: The main outcome was number of SUD symptoms based on Diagnostic and Statistical Manual, 5th edition (DSM-5), reported on Symptom Checklists (0-11) for alcohol or other drugs: 2-3 mild; 4-5 moderate; 6-11 severe. RESULTS: Of screened patients, 16,776 (5.7%) reported high-risk use of alcohol (2.4%), cannabis (3.9%), and/or other drugs (1.7%), and 65.0-69.9% of those completed Symptom Checklists. Of those with high-risk alcohol use, 52.5% (95% CI 50.9-54.0%) reported ≥ 2 symptoms consistent with mild-severe alcohol use disorders. Of those reporting daily cannabis use, 29.8% (28.6-30.9%) reported ≥ 2 symptoms consistent with mild-severe SUDs. Of those reporting any other drug use, 37.5% (35.7-39.3%) reported ≥ 2 symptoms consistent with mild-severe SUDs. CONCLUSIONS AND RELEVANCE: Many PC patients who screened positive for high-risk substance use reported symptoms consistent with DSM-5 SUDs on self-report Symptom Checklists. Use of SUD Symptom Checklists could support PC providers in making SUD diagnoses and initiating discussions of substance use.
BACKGROUND: Most patients with substance use disorders (SUDs) never receive treatment and SUDs are under-recognized in primary care (PC) where patients can be treated or linked to treatment. Asking PC patients to directly report SUD symptoms on questionnaires might help identify SUDs but to our knowledge, this approach is previously untested. OBJECTIVE: To describe the prevalence and severity of DSM-5 SUD symptoms reported by PC patients as part of routine care. DESIGN: Cross-sectional study using secondary data. PARTICIPANTS: A total of 241,265 adult patients who visited one of 25 PC sites in an integrated health system in Washington state and had alcohol, cannabis, or other drug use screening documented in their EHRs (March 2015-July 2018) were included in main analyses if they had a positive screen for high-risk substance use defined as AUDIT-C score 7-12 points, or report of past-year daily cannabis use or any other drug use. MAIN MEASURES: The main outcome was number of SUD symptoms based on Diagnostic and Statistical Manual, 5th edition (DSM-5), reported on Symptom Checklists (0-11) for alcohol or other drugs: 2-3 mild; 4-5 moderate; 6-11 severe. RESULTS: Of screened patients, 16,776 (5.7%) reported high-risk use of alcohol (2.4%), cannabis (3.9%), and/or other drugs (1.7%), and 65.0-69.9% of those completed Symptom Checklists. Of those with high-risk alcohol use, 52.5% (95% CI 50.9-54.0%) reported ≥ 2 symptoms consistent with mild-severe alcohol use disorders. Of those reporting daily cannabis use, 29.8% (28.6-30.9%) reported ≥ 2 symptoms consistent with mild-severe SUDs. Of those reporting any other drug use, 37.5% (35.7-39.3%) reported ≥ 2 symptoms consistent with mild-severe SUDs. CONCLUSIONS AND RELEVANCE: Many PC patients who screened positive for high-risk substance use reported symptoms consistent with DSM-5 SUDs on self-report Symptom Checklists. Use of SUD Symptom Checklists could support PC providers in making SUD diagnoses and initiating discussions of substance use.
Entities:
Keywords:
addiction; alcohol; behavioral health; cannabis; drug use; primary care; screening; substance use; substance use disorders
Authors: Joseph E Glass; Ashley M Hamilton; Byron J Powell; Brian E Perron; Randall T Brown; Mark A Ilgen Journal: Addiction Date: 2015-10-13 Impact factor: 6.526
Authors: Katherine E Watkins; Allison J Ober; Karen Lamp; Mimi Lind; Claude Setodji; Karen Chan Osilla; Sarah B Hunter; Colleen M McCullough; Kirsten Becker; Praise O Iyiewuare; Allison Diamant; Keith Heinzerling; Harold Alan Pincus Journal: JAMA Intern Med Date: 2017-10-01 Impact factor: 21.873
Authors: Gwen T Lapham; Amy K Lee; Ryan M Caldeiro; Dennis McCarty; Kendall C Browne; Denise D Walker; Daniel R Kivlahan; Katharine A Bradley Journal: J Am Board Fam Med Date: 2017 Nov-Dec Impact factor: 2.657
Authors: Rachel Humeniuk; Robert Ali; Thomas F Babor; Michael Farrell; Maria L Formigoni; Jaroon Jittiwutikarn; Roseli B de Lacerda; Walter Ling; John Marsden; Maristela Monteiro; Sekai Nhiwatiwa; Hemraj Pal; Vladimir Poznyak; Sara Simon Journal: Addiction Date: 2008-03-28 Impact factor: 6.526
Authors: Jennifer McNeely; Li-Tzy Wu; Geetha Subramaniam; Gaurav Sharma; Lauretta A Cathers; Dace Svikis; Luke Sleiter; Linnea Russell; Courtney Nordeck; Anjalee Sharma; Kevin E O'Grady; Leah B Bouk; Carol Cushing; Jacqueline King; Aimee Wahle; Robert P Schwartz Journal: Ann Intern Med Date: 2016-09-06 Impact factor: 25.391
Authors: Joseph E Glass; Jennifer F Bobb; Amy K Lee; Julie E Richards; Gwen T Lapham; Evette Ludman; Carol Achtmeyer; Ryan M Caldeiro; Rebecca Parrish; Emily C Williams; Paula Lozano; Katharine A Bradley Journal: Implement Sci Date: 2018-08-06 Impact factor: 7.327
Authors: Kevin A Hallgren; Theresa E Matson; Malia Oliver; Katie Witkiewitz; Jennifer F Bobb; Amy K Lee; Ryan M Caldeiro; Daniel Kivlahan; Katharine A Bradley Journal: J Gen Intern Med Date: 2021-08-16 Impact factor: 6.473
Authors: Madeline C Frost; Theresa E Matson; Julie E Richards; Amy K Lee; Carol E Achtmeyer; Katharine A Bradley; Emily C Williams Journal: Subst Abus Date: 2022 Impact factor: 3.984
Authors: David S Carrell; David J Cronkite; Mary Shea; Malia Oliver; Casey Luce; Theresa E Matson; Jennifer F Bobb; Clarissa Hsu; Ingrid A Binswanger; Kendall C Browne; Andrew J Saxon; Jennifer McCormack; Eve Jelstrom; Udi E Ghitza; Cynthia I Campbell; Katharine A Bradley; Gwen T Lapham Journal: Subst Abus Date: 2022 Impact factor: 3.984
Authors: Theresa E Matson; Gwen T Lapham; Jennifer F Bobb; Eric Johnson; Julie E Richards; Amy K Lee; Katharine A Bradley; Joseph E Glass Journal: Drug Alcohol Depend Date: 2020-08-08 Impact factor: 4.492
Authors: Jennifer McNeely; Angéline Adam; John Rotrosen; Sarah E Wakeman; Timothy E Wilens; Joseph Kannry; Richard N Rosenthal; Aimee Wahle; Seth Pitts; Sarah Farkas; Carmen Rosa; Lauren Peccoralo; Eva Waite; Aida Vega; Jennifer Kent; Catherine K Craven; Tamar A Kaminski; Elizabeth Firmin; Benjamin Isenberg; Melanie Harris; Andre Kushniruk; Leah Hamilton Journal: JAMA Netw Open Date: 2021-05-03
Authors: Theresa E Matson; David S Carrell; Jennifer F Bobb; David J Cronkite; Malia M Oliver; Casey Luce; Udi E Ghitza; Clarissa W Hsu; Cynthia I Campbell; Kendall C Browne; Ingrid A Binswanger; Andrew J Saxon; Katharine A Bradley; Gwen T Lapham Journal: JAMA Netw Open Date: 2021-05-03
Authors: Kevin A Hallgren; Theresa E Matson; Malia Oliver; Ryan M Caldeiro; Daniel R Kivlahan; Katharine A Bradley Journal: Alcohol Clin Exp Res Date: 2022-03 Impact factor: 3.455
Authors: Justin S Tauscher; Eliza B Cohn; Tascha R Johnson; Kaylie D Diteman; Richard K Ries; David C Atkins; Kevin A Hallgren Journal: Addict Sci Clin Pract Date: 2021-06-15